Skip to main content

TESTOSTERONE ADVZ (Boucher & Muir Pty Ltd)

Product name
TESTOSTERONE ADVZ
Date registered
Evaluation commenced
Decision date
Approval time
85 (120 working days)
Active ingredients
testosterone undecanoate
Registration type
New generic medicine
Indication

Testosterone replacement in primary and secondary male hypogonadism

Registration process

First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine

Help us improve the Therapeutic Goods Administration site